A detailed history of D. E. Shaw & Co., Inc. transactions in Bioventus Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 197,175 shares of BVS stock, worth $2.33 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
197,175
Holding current value
$2.33 Million
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$3.96 - $6.93 $780,813 - $1.37 Million
197,175 New
197,175 $1.13 Million
Q4 2023

Feb 14, 2024

BUY
$2.89 - $5.34 $103,779 - $191,759
35,910 New
35,910 $189,000
Q1 2023

May 15, 2023

BUY
$1.07 - $2.95 $6,099 - $16,815
5,700 Added 45.24%
18,300 $19,000
Q4 2022

Feb 14, 2023

BUY
$1.81 - $8.14 $22,806 - $102,564
12,600 New
12,600 $32,000
Q4 2021

Feb 14, 2022

SELL
$12.37 - $16.77 $185,846 - $251,952
-15,024 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$13.7 - $17.25 $205,828 - $259,164
15,024 New
15,024 $213,000

Others Institutions Holding BVS

About Bioventus Inc.


  • Ticker BVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 61,664,200
  • Market Cap $729M
  • Description
  • Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...
More about BVS
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.